Hybio Pharmaceutica Co.,Ltd
Business Type:Trading Company
- Main Products:
- Peptide Drug products:Desmopressin for injection, Carbetocin for injection, Oxytocin for injection, Terlipressin for injection,Liraglutide injection... Peptide APIs: Liraglutide, Glatiramer, Desmopressin, Linaclotide, Ganirelix, Teriparatide...
- Year Established:
- 2018
Hybio Pharmaceutical Co., Ltd., a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptides, founded in 2003, is one of pioneers who are firstly dedicated in peptide field in China. Hybio was also the first listed peptide company in China and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services. API facility has been approved by USFDA, EU and also KFDA; FD f...
MoreCompany Authentication
Time of verification: | ||
Company Name: | ||
Country/Territory: | ||
Registered Address: | Hybio Medicine Park, No. 37, Keji C. Str 2nd Shenzhen Hi-tech Industrial Park 518057 P.R.China | |
Company Scale: |
||
Registered Capital: |
||
Business Type: |
False |
|
Business Scope: |
Peptide Drug products:Desmopressin for injection, Carbetocin for injection, Oxytocin for injection, Terlipressin for injection,Liraglutide injection... Peptide APIs: Liraglutide, Glatiramer, Desmopressin, Linaclotide, Ganirelix, Teriparatide... |
|
Main Markets: |
North America South America Eastern Europe Southeast Asia Oceania Mid East Eastern Asia Western Europe |
|
Company Corporate Representative: |
Certificate
Business License: |
Tax Registration Certificate: |
Organization Code Certificate: |
Legal person's id card: |
